Skip Nav Destination
Issues
1 January 2015
eISSN 2168-9709
In this Issue
Examining the Impact of the Psychiatric Pharmacist, Vol. 5, Iss. 1
CPNP POSITION PAPER
Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team
Lisa W. Goldstone, MS, PharmD, BCPS, BCPP; Bethany A. DiPaula, PharmD, BCPP; Joshua Caballero, PharmD, BCPP; Susie H. Park, PharmD, BCPP; Cristofer Price, PharmD, BCPP; Magdalena Zasadzki Slater, PharmD, BCPS, BCPP
ORIGINAL RESEARCH
INNOVATIVE PRACTICE
-
Cover Image
Cover Image
Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements
Kelly C. Lee, PharmD, MAS, BCPP, Richard J. Silvia, PharmD, BCPP, Gregory H. Payne, MBA, Tera D. Moore, PharmD, BCACP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP
Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
Richard J. Silvia, PharmD, BCPP, Kelly C. Lee, PharmD, MAS, BCPP, Gregory H. Payne, MBA, Jessica Ho, PharmD, BCPS, BCPP, Carla Cobb, PharmD, BCPP, Elayne D. Ansara, PharmD, BCPS, BCPP, Clint A. Ross, PharmD, BCPP
Positioning psychiatric pharmacists to improve mental health care
Julie A. Dopheide, PharmD, BCPP, FASHP, Amy Werremeyer, PharmD, BCPP, Robert J. Haight, PharmD, BCPP, Cynthia A. Gutierrez, PharmD, MS, BCPP, Andrew M. Williams, PharmD, BCPP
Ambitious AAPP vision necessitates bold actions
Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Cherry W. Jackson, PharmD, FASHP, FCCP, BCPP